1.
|
Phase: Phase III Type: Treatment Status: Active Age: Geriatric Sponsor: Other, Pharmaceutical / Industry Protocol IDs: GCLLSG-CLL9, EU-20561, AMGEN-GCLLSG-CLL9, EUDRACT-2005-003014-15, NCT00281892
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20070782, NCT00858364
|
|
3.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: MDS201001, 2009-017462-23, CRUK/08/009, NCT01196715
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20090160, NCT01362140
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GFM-DAR500-2006-01, NCT00443339
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: KRN321-401, NCT01497145
|
|
7.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CDR0000458037, WGSG-ARA-PLUS, AVENTIS-WGSG-ARA-PLUS, SANOFI-WGSF-ARA-PLUS, EU-205108, NCT00309920
|